Aileron Therapeutics SG&A Expense (TTM) Trends

Aileron Therapeutics Inc (ALRN)

3.09 +0.22 (+7.67%) USD | NASDAQ | Jul 08, 16:00

3.09 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
March 31, 2024	12.92M
December 31, 2023	11.36M
September 30, 2023	8.328M
June 30, 2023	8.616M
March 31, 2023	9.331M
December 31, 2022	9.68M
September 30, 2022	9.634M
June 30, 2022	9.904M
March 31, 2022	9.452M
December 31, 2021	9.597M
September 30, 2021	9.609M
June 30, 2021	9.44M
March 31, 2021	9.196M
December 31, 2020	9.33M
September 30, 2020	9.702M

Date	Value
June 30, 2020	10.80M
March 31, 2020	11.96M
December 31, 2019	12.29M
September 30, 2019	12.68M
June 30, 2019	12.41M
March 31, 2019	13.68M
December 31, 2018	13.45M
September 30, 2018	13.16M
June 30, 2018	12.59M
March 31, 2018	10.04M
December 31, 2017	8.769M
September 30, 2017	7.395M
June 30, 2017	6.421M
March 31, 2017	8.094M
December 31, 2016	7.893M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

8.328M

Minimum

Sep 2023

12.92M

Maximum

Mar 2024

10.20M

Average

9.634M

Median

Sep 2022

SG&A Expense (TTM) Benchmarks